The Next Generation of Molecular and Cellular Therapeutics for Inherited Retinal Disease
Inherited retinal degenerations (IRDs) are a diverse group of conditions that are often characterized by the loss of photoreceptors and blindness. Recent innovations in molecular biology and genomics have allowed us to identify the causative defects behind these dystrophies and to design therapeutic...
Guardado en:
Autores principales: | Luis A. Martinez Velazquez, Brian G. Ballios |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/57fe87b80315410892a4f5e17fdcc0e3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prime Editing for Inherited Retinal Diseases
por: Bruna Lopes da Costa, et al.
Publicado: (2021) -
Voretigene Neparvovec in Retinal Diseases: A Review of the Current Clinical Evidence
por: Gao J, et al.
Publicado: (2020) -
Descriptive Study of a Cohort of 488 Patients with Inherited Retinal Dystrophies
por: Coco-Martin RM, et al.
Publicado: (2021) -
Random-PE: an efficient integration of random sequences into mammalian genome by prime editing
por: Yaoge Jiao, et al.
Publicado: (2021) -
Gene Therapies for Monogenic Autism Spectrum Disorders
por: Wout Weuring, et al.
Publicado: (2021)